Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins c-myc | 8 | 2021 | 988 | 1.490 |
Why?
|
RNA Polymerase II | 7 | 2022 | 539 | 1.070 |
Why?
|
Transcription, Genetic | 6 | 2022 | 7595 | 0.660 |
Why?
|
Transcriptional Elongation Factors | 1 | 2019 | 165 | 0.590 |
Why?
|
Promoter Regions, Genetic | 9 | 2022 | 5789 | 0.380 |
Why?
|
DNA Breaks, Double-Stranded | 4 | 2024 | 612 | 0.370 |
Why?
|
DNA Replication | 4 | 2021 | 1418 | 0.280 |
Why?
|
Nuclear Proteins | 2 | 2019 | 5794 | 0.240 |
Why?
|
Cell Cycle | 3 | 2020 | 2932 | 0.210 |
Why?
|
RNA Polymerase I | 1 | 2022 | 22 | 0.210 |
Why?
|
Cell Proliferation | 4 | 2021 | 10441 | 0.190 |
Why?
|
Sumoylation | 1 | 2022 | 83 | 0.190 |
Why?
|
Transcription Factors | 5 | 2024 | 12125 | 0.180 |
Why?
|
S Phase | 2 | 2022 | 421 | 0.180 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2022 | 367 | 0.180 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 1726 | 0.180 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 294 | 0.170 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 359 | 0.170 |
Why?
|
Cysteine Endopeptidases | 1 | 2022 | 551 | 0.160 |
Why?
|
Histone Chaperones | 1 | 2019 | 83 | 0.160 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2019 | 181 | 0.160 |
Why?
|
Chlamydia trachomatis | 1 | 2020 | 239 | 0.160 |
Why?
|
Peptidoglycan | 1 | 2020 | 249 | 0.150 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 502 | 0.150 |
Why?
|
Cyclooxygenase 2 | 1 | 2020 | 597 | 0.150 |
Why?
|
Immune Evasion | 1 | 2021 | 363 | 0.150 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2020 | 373 | 0.150 |
Why?
|
Cell Line, Tumor | 8 | 2021 | 16979 | 0.150 |
Why?
|
Glutamine | 1 | 2020 | 577 | 0.140 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2022 | 1893 | 0.140 |
Why?
|
Exosomes | 1 | 2021 | 424 | 0.140 |
Why?
|
Chlamydia Infections | 1 | 2020 | 365 | 0.140 |
Why?
|
Chromatin | 4 | 2022 | 2960 | 0.130 |
Why?
|
Neuroblastoma | 2 | 2021 | 1250 | 0.130 |
Why?
|
BRCA1 Protein | 2 | 2021 | 1155 | 0.130 |
Why?
|
Cell Nucleus | 2 | 2021 | 2908 | 0.130 |
Why?
|
Oncogene Proteins | 1 | 2020 | 718 | 0.130 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 655 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 1405 | 0.120 |
Why?
|
Thalidomide | 1 | 2020 | 885 | 0.120 |
Why?
|
DNA Repair | 2 | 2022 | 2045 | 0.120 |
Why?
|
RNA, Ribosomal | 1 | 2015 | 227 | 0.120 |
Why?
|
Mitosis | 1 | 2019 | 1187 | 0.110 |
Why?
|
Neoplasms | 2 | 2020 | 22164 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2022 | 5365 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2020 | 11902 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 2898 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1405 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6935 | 0.090 |
Why?
|
Apoptosis | 3 | 2022 | 9488 | 0.090 |
Why?
|
Cell Cycle Proteins | 2 | 2019 | 3447 | 0.090 |
Why?
|
Drosophila | 1 | 2017 | 1495 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8545 | 0.090 |
Why?
|
Trans-Activators | 1 | 2019 | 2856 | 0.080 |
Why?
|
Gene Expression | 1 | 2022 | 7584 | 0.080 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9606 | 0.080 |
Why?
|
Drosophila Proteins | 1 | 2017 | 1699 | 0.080 |
Why?
|
DNA | 2 | 2024 | 7219 | 0.070 |
Why?
|
HEK293 Cells | 3 | 2021 | 4278 | 0.070 |
Why?
|
Mice | 9 | 2022 | 81509 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5665 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6339 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9418 | 0.050 |
Why?
|
RNA Precursors | 1 | 2024 | 212 | 0.050 |
Why?
|
Humans | 20 | 2024 | 761423 | 0.050 |
Why?
|
Etoposide | 1 | 2024 | 634 | 0.050 |
Why?
|
Carbon-Nitrogen Lyases | 1 | 2022 | 8 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2022 | 3602 | 0.050 |
Why?
|
Cell Nucleolus | 1 | 2022 | 156 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5709 | 0.050 |
Why?
|
Protein Binding | 3 | 2020 | 9352 | 0.050 |
Why?
|
RNA Caps | 1 | 2021 | 73 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 2 | 2022 | 2803 | 0.050 |
Why?
|
Indoleacetic Acids | 1 | 2021 | 44 | 0.050 |
Why?
|
Exoribonucleases | 1 | 2021 | 93 | 0.050 |
Why?
|
Cell Line | 3 | 2021 | 15605 | 0.050 |
Why?
|
Animals | 10 | 2022 | 168441 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5819 | 0.050 |
Why?
|
Amino Acid Transport System ASC | 1 | 2020 | 16 | 0.050 |
Why?
|
Polyadenylation | 1 | 2021 | 117 | 0.040 |
Why?
|
Activating Transcription Factor 4 | 1 | 2020 | 84 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2021 | 671 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-2B | 1 | 2019 | 9 | 0.040 |
Why?
|
Ribosomal Proteins | 1 | 2022 | 371 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2022 | 426 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2020 | 293 | 0.040 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2019 | 181 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2019 | 404 | 0.040 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2020 | 259 | 0.040 |
Why?
|
Benzazepines | 1 | 2020 | 310 | 0.040 |
Why?
|
Introns | 1 | 2021 | 981 | 0.040 |
Why?
|
Thiolester Hydrolases | 1 | 2019 | 91 | 0.040 |
Why?
|
Transcription Factors, TFIII | 1 | 2017 | 10 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2022 | 22163 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2020 | 705 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2016 | 2020 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4741 | 0.040 |
Why?
|
Dinoprostone | 1 | 2020 | 597 | 0.040 |
Why?
|
Tumor Escape | 1 | 2020 | 370 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 641 | 0.040 |
Why?
|
Genomic Instability | 1 | 2022 | 709 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13637 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 802 | 0.040 |
Why?
|
DNA, Intergenic | 1 | 2017 | 105 | 0.040 |
Why?
|
Feedback, Physiological | 1 | 2019 | 476 | 0.040 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2017 | 122 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 30045 | 0.040 |
Why?
|
Protein Stability | 1 | 2019 | 578 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1827 | 0.030 |
Why?
|
Biological Transport | 1 | 2021 | 2092 | 0.030 |
Why?
|
Ubiquitination | 1 | 2021 | 1006 | 0.030 |
Why?
|
Signal Recognition Particle | 1 | 2015 | 47 | 0.030 |
Why?
|
RNA, Small Cytoplasmic | 1 | 2015 | 19 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1612 | 0.030 |
Why?
|
Immune System | 1 | 2021 | 795 | 0.030 |
Why?
|
Drug Design | 1 | 2020 | 1048 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2024 | 1897 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1188 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3614 | 0.030 |
Why?
|
Binding Sites | 1 | 2022 | 6055 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2022 | 1974 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2016 | 855 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2667 | 0.030 |
Why?
|
Up-Regulation | 1 | 2022 | 4124 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 18964 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 3969 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1363 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6215 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2019 | 2114 | 0.030 |
Why?
|
DNA Damage | 1 | 2022 | 2446 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1458 | 0.020 |
Why?
|
Colon | 1 | 2019 | 1792 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2723 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2020 | 2863 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2916 | 0.020 |
Why?
|
Motor Neurons | 1 | 2015 | 870 | 0.020 |
Why?
|
Histones | 1 | 2021 | 2580 | 0.020 |
Why?
|
Breast | 1 | 2019 | 1966 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9535 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2811 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2448 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 3061 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 12796 | 0.020 |
Why?
|
Cell Movement | 1 | 2019 | 5203 | 0.020 |
Why?
|
Axons | 1 | 2015 | 1674 | 0.020 |
Why?
|
Female | 6 | 2022 | 392581 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10089 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23441 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13337 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12720 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2016 | 3576 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2016 | 3667 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11526 | 0.010 |
Why?
|
Male | 4 | 2021 | 360736 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18247 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29620 | 0.010 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_